You are viewing the public part of the archive. Login or request access to view more content.

Displaying 1-7 of 7 results
00:13:04

2012_95

XIX International AIDS Conference in Washington D.C. Gottfried Hirnshall is Director of Department of HIV and Global Hepatitis Programme at the WHO. Here he talks about what needs to be done from a health policy perspective to end AIDS, and the role of WHO.

2012_95

02:49:37

2012_24

Closing session of the XIX International AIDS Conference with speakers such as Bill Clinton, the two co-chairs of the conference Elly Katabira and Diane Havlir, US politician Nancy Pelosi, Françoise Barré-Sinoussi, and many activists and community leaders.

2012_24

00:23:53

2008_69_02

XVII International AIDS Conference in Mexico City. Interviews with Jasmine Burnett from the Black AIDS Institute in the United States, Yvette Fleming from Stop AIDS Now in the Netherlands and David Lush from Positive Vibes in Namibia, among others.

2008_69_02

00:26:40

2006_13_03

Last part of the interview with the American AIDS activist and founder of Project Inform, Martin Delaney, in 2006. Here he talks about AIDS activism and the different stages of the antiretroviral drug development from AZT to triple combination treatment.

2006_13_03

00:11:57

2003_11_03

Interview with George Louis, Professor and Director at the division of Vaccine and Research at the Initiative of Human Virology (IHV) in Baltimore. He talks about the current HIV vaccine trials and reflects on the future.

2003_11_03

00:11:05

1992_6

Geoffrey Schild, Virologist and Director of the National Institute for Biological Standards and Control (NIBSC), talks about the Swedish contributions to AIDS research and collaboration with funding agencies such as Nutek, and reflects on HIV vaccines.

1992_6

00:07:41

1992_5

Dr George Galasso is working on HIV vaccines at NIAID. Here he talks about the scientific challenges of HIV/AIDS and the chances of developing a vaccine. He believes that one of the main focuses in HIV/AIDS research still is to find treatment for opportunistic infections.

1992_5